Invention Grant
- Patent Title: STAT6 inhibitors
-
Application No.: US14889802Application Date: 2014-05-08
-
Publication No.: US09765099B2Publication Date: 2017-09-19
- Inventor: John S. McMurray , Pijus Kumar Mandal , Pietro Morlacchi , Morgan Knight , David B. Corry
- Applicant: Board of Regents, The University of Texas System , Baylor College of Medicine
- Applicant Address: US TX Austin US TX Houston
- Assignee: Board of Regents, The University of Texas System,Baylor College of Medicine
- Current Assignee: Board of Regents, The University of Texas System,Baylor College of Medicine
- Current Assignee Address: US TX Austin US TX Houston
- Agency: Parker Highlander PLLC
- International Application: PCT/US2014/037342 WO 20140508
- International Announcement: WO2014/182928 WO 20141113
- Main IPC: C07D223/10
- IPC: C07D223/10 ; C07F9/6561 ; A61K45/06 ; A61K9/00 ; C07F9/553 ; C07F9/572 ; C07F9/60 ; C07F9/62 ; C07F9/6509 ; C07F9/6533 ; C07F9/6558 ; C07F9/12 ; C07K5/078 ; C07K5/062

Abstract:
The present disclosure provides compounds that are useful for inhibiting the STAT6 pathway. Also provided are related pharmaceutical compositions and methods of using the compounds. In some embodiments, the compounds may be used to treat a disease such as, e.g., an allergic lung disease, allergic rhinitis, chronic pulmonary obstructive disease, or a cancer.
Public/Granted literature
- US20160145279A1 STAT6 INHIBITORS Public/Granted day:2016-05-26
Information query